Scroll | 20/01/2022 12:30 PM | Click to read full article
The subject expert panel on Covid-19 vaccines on Wednesday recommended to the Central Drugs Standard Control Organisation that Covishield and Covaxin be granted regular market approval. Currently, the vaccines have clearance for restricted use in emergency situations.
The regulatory authority also said that it has recommended certain conditions for granting of the new drug permission. However, it did not specify the conditions.